Skip to main content
Erschienen in: Surgical Endoscopy 12/2008

01.12.2008 | Technique

Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma

verfasst von: Alberto Patriti, Graziano Ceccarelli, Raffaele Bellochi, Alberto Bartoli, Alessandro Spaziani, Lelio Di Zitti, Luciano Casciola

Erschienen in: Surgical Endoscopy | Ausgabe 12/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Lymph node dissection and esophageal anastomosis, considered the more demanding steps of laparoscopic gastrectomy for gastric adenocarcinoma, can be performed with the use of a remote-controlled robot.

Methods

Thirteen patients with a histologically proved gastric cancer (six stage I, six stage II, and one stage III) were enrolled in a prospective study to assess feasibility and safety of the Da Vinci surgical system in total and partial gastrectomy with extended lymph node dissection. Outcome measures were conversion rate, intra- and postoperative morbidity and mortality, operative time, blood loss, number of lymph nodes harvested, and macroscopic and microscopic evaluation of resection margins.

Results

Eight distal, four total, and one proximal laparoscopic gastrectomies were completed without conversion. Extended lymph node dissection, and esophagojejunal and esophagogastric anastomoses were successfully carried out using the da Vinci System. Mean operative time was 286 ± 32.6 min and blood loss was 103 ± 87.5 ml. Mean number of nodes retrieved was 28.1 ± 8.3 and all resection margins were negative. There was no mortality. Trocar bleeding requiring laparoscopy was the only major complication encountered. No recurrence occurred during a mean follow-up time of 12.2 ± 4.5 months.

Conclusions

Robot-assisted laparoscopic lymph node dissection and esophageal anastomosis are feasible and safe. Longer follow-up time and randomized studies are needed to evaluate long-term outcome and clinical advantages of this new technology.
Literatur
1.
Zurück zum Zitat Cuschieri A, Weeden S, Fielding J et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522–1530PubMedCrossRef Cuschieri A, Weeden S, Fielding J et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522–1530PubMedCrossRef
2.
Zurück zum Zitat Shiraishi N, Yasuda K, Kitano S (2006) Laparoscopic gastrectomy with lymph node dissection for gastric cancer. Gastric Cancer 9:167–176PubMedCrossRef Shiraishi N, Yasuda K, Kitano S (2006) Laparoscopic gastrectomy with lymph node dissection for gastric cancer. Gastric Cancer 9:167–176PubMedCrossRef
3.
Zurück zum Zitat Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908–914PubMedCrossRef Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908–914PubMedCrossRef
4.
Zurück zum Zitat Onate-Ocana LF, Aiello-Crocifoglio V, Mondragon-Sanchez R, Ruiz-Molina JM (2000) Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 7:210–217PubMedCrossRef Onate-Ocana LF, Aiello-Crocifoglio V, Mondragon-Sanchez R, Ruiz-Molina JM (2000) Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 7:210–217PubMedCrossRef
5.
Zurück zum Zitat Goh P, Kum CK (1993) Laparoscopic Billroth II gastrectomy: a review. Surg Oncol 2(Suppl 1):13–18PubMedCrossRef Goh P, Kum CK (1993) Laparoscopic Billroth II gastrectomy: a review. Surg Oncol 2(Suppl 1):13–18PubMedCrossRef
6.
Zurück zum Zitat Huscher CG, Mingoli A, Sgarzini G et al (2005) Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 241:232–237PubMedCrossRef Huscher CG, Mingoli A, Sgarzini G et al (2005) Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 241:232–237PubMedCrossRef
7.
Zurück zum Zitat Adachi Y, Shiraishi N, Shiromizu A, Bandoh T, Aramaki M, Kitano S (2000) Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy. Arch Surg 135:806–810PubMedCrossRef Adachi Y, Shiraishi N, Shiromizu A, Bandoh T, Aramaki M, Kitano S (2000) Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy. Arch Surg 135:806–810PubMedCrossRef
8.
Zurück zum Zitat Shehzad K, Mohiuddin K, Nizami S et al (2007) Current status of minimal access surgery for gastric cancer. Surg Oncol 16:85–98PubMedCrossRef Shehzad K, Mohiuddin K, Nizami S et al (2007) Current status of minimal access surgery for gastric cancer. Surg Oncol 16:85–98PubMedCrossRef
9.
Zurück zum Zitat Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW (2002) Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 14:115–122PubMedCrossRef Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW (2002) Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 14:115–122PubMedCrossRef
10.
Zurück zum Zitat Kim JJ, Song KY, Chin HM et al (2008) Totally laparoscopic gastrectomy with various types of intracorporeal anastomosis using laparoscopic linear staplers: preliminary experience. Surg Endosc 22:436–442PubMedCrossRef Kim JJ, Song KY, Chin HM et al (2008) Totally laparoscopic gastrectomy with various types of intracorporeal anastomosis using laparoscopic linear staplers: preliminary experience. Surg Endosc 22:436–442PubMedCrossRef
11.
Zurück zum Zitat Gutt CN, Oniu T, Mehrabi A, Kashfi A, Schemmer P, Buchler MW (2004) Robot-assisted abdominal surgery. Br J Surg 91:1390–1397PubMedCrossRef Gutt CN, Oniu T, Mehrabi A, Kashfi A, Schemmer P, Buchler MW (2004) Robot-assisted abdominal surgery. Br J Surg 91:1390–1397PubMedCrossRef
12.
Zurück zum Zitat Patel VR, Chammas MF Jr, Shah S (2007) Robotic assisted laparoscopic radical prostatectomy: a review of the current state of affairs. Int J Clin Pract 61:309–314PubMedCrossRef Patel VR, Chammas MF Jr, Shah S (2007) Robotic assisted laparoscopic radical prostatectomy: a review of the current state of affairs. Int J Clin Pract 61:309–314PubMedCrossRef
13.
Zurück zum Zitat Giulianotti PC, Coratti A, Angelini M et al (2003) Robotics in general surgery: personal experience in a large community hospital. Arch Surg 138:777–784PubMedCrossRef Giulianotti PC, Coratti A, Angelini M et al (2003) Robotics in general surgery: personal experience in a large community hospital. Arch Surg 138:777–784PubMedCrossRef
14.
Zurück zum Zitat Cancer JRSfG (1995) Japanese classification of gastric carcinoma. Kanehara, Tokyo Cancer JRSfG (1995) Japanese classification of gastric carcinoma. Kanehara, Tokyo
15.
Zurück zum Zitat Siewert JR, Feith M, Stein HJ (2005) Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 90:139–146; discussion 146PubMedCrossRef Siewert JR, Feith M, Stein HJ (2005) Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 90:139–146; discussion 146PubMedCrossRef
16.
Zurück zum Zitat Casciola L, Codacci-Pisanelli M, Ceccarelli G, Bartoli A, Di Zitti L, Patriti A (2008) A modified umbilical incision for specimen extraction after laparoscopic abdominal surgery. Surg Endosc 22:784–786PubMedCrossRef Casciola L, Codacci-Pisanelli M, Ceccarelli G, Bartoli A, Di Zitti L, Patriti A (2008) A modified umbilical incision for specimen extraction after laparoscopic abdominal surgery. Surg Endosc 22:784–786PubMedCrossRef
17.
Zurück zum Zitat Kernstine KH, DeArmond DT, Karimi M et al (2004) The robotic, 2-stage, 3-field esophagolymphadenectomy. J Thorac Cardiovasc Surg 127:1847–1849PubMedCrossRef Kernstine KH, DeArmond DT, Karimi M et al (2004) The robotic, 2-stage, 3-field esophagolymphadenectomy. J Thorac Cardiovasc Surg 127:1847–1849PubMedCrossRef
18.
Zurück zum Zitat Costi R, Himpens J, Essola B et al (2004) Totally laparoscopic esophago-gastrectomy. Acta Biomed 75:188–191PubMed Costi R, Himpens J, Essola B et al (2004) Totally laparoscopic esophago-gastrectomy. Acta Biomed 75:188–191PubMed
19.
Zurück zum Zitat Anderson C, Ellenhorn J, Hellan M, Pigazzi A (2007) Pilot series of robot-assisted laparoscopic subtotal gastrectomy with extended lymphadenectomy for gastric cancer. Surg Endosc 21:1662–1666PubMedCrossRef Anderson C, Ellenhorn J, Hellan M, Pigazzi A (2007) Pilot series of robot-assisted laparoscopic subtotal gastrectomy with extended lymphadenectomy for gastric cancer. Surg Endosc 21:1662–1666PubMedCrossRef
20.
Zurück zum Zitat Hur H, Jeon HM, Kim W (2008) Laparoscopic pancreas- and spleen-preserving D2 lymph node dissection in advanced (cT2) upper-third gastric cancer. J Surg Oncol 97:169–172PubMedCrossRef Hur H, Jeon HM, Kim W (2008) Laparoscopic pancreas- and spleen-preserving D2 lymph node dissection in advanced (cT2) upper-third gastric cancer. J Surg Oncol 97:169–172PubMedCrossRef
21.
Zurück zum Zitat Ballantyne GH (2007) Telerobotic gastrointestinal surgery: phase 2—safety and efficacy. Surg Endosc 21:1054–1062PubMedCrossRef Ballantyne GH (2007) Telerobotic gastrointestinal surgery: phase 2—safety and efficacy. Surg Endosc 21:1054–1062PubMedCrossRef
22.
Zurück zum Zitat Huscher CG, Mingoli A, Sgarzini G et al (2007) Totally laparoscopic total and subtotal gastrectomy with extended lymph node dissection for early and advanced gastric cancer: early and long-term results of a 100-patient series. Am J Surg 194:839–844; discussion 844PubMedCrossRef Huscher CG, Mingoli A, Sgarzini G et al (2007) Totally laparoscopic total and subtotal gastrectomy with extended lymph node dissection for early and advanced gastric cancer: early and long-term results of a 100-patient series. Am J Surg 194:839–844; discussion 844PubMedCrossRef
23.
Zurück zum Zitat Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRef Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRef
24.
Zurück zum Zitat Baeza MR, Giannini TO, Rivera SR et al (2001) Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer. Int J Radiat Oncol Biol Phys 50:645–650PubMed Baeza MR, Giannini TO, Rivera SR et al (2001) Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer. Int J Radiat Oncol Biol Phys 50:645–650PubMed
25.
Zurück zum Zitat Nishikawa T, Maetani S (2007) Evaluation of intensive adjuvant chemotherapy in gastric cancer using life expectancy compared with log-rank test as a measure of survival benefit. Ann Surg Oncol 14:348–354PubMedCrossRef Nishikawa T, Maetani S (2007) Evaluation of intensive adjuvant chemotherapy in gastric cancer using life expectancy compared with log-rank test as a measure of survival benefit. Ann Surg Oncol 14:348–354PubMedCrossRef
26.
Zurück zum Zitat Popiela T, Kulig J, Czupryna A, Szczepanik AM, Zembala M (2004) Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer 7:240–245PubMedCrossRef Popiela T, Kulig J, Czupryna A, Szczepanik AM, Zembala M (2004) Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer 7:240–245PubMedCrossRef
Metadaten
Titel
Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma
verfasst von
Alberto Patriti
Graziano Ceccarelli
Raffaele Bellochi
Alberto Bartoli
Alessandro Spaziani
Lelio Di Zitti
Luciano Casciola
Publikationsdatum
01.12.2008
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 12/2008
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-008-0129-0

Weitere Artikel der Ausgabe 12/2008

Surgical Endoscopy 12/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.